BioPharmSignal logoBioPharmSignal

Biotech News

Synlogic Reports First Quarter 2024 Financial Results

Synlogic (SYBX)SynlogicEarnings

CAMBRIDGE, Mass. , May 14, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the first quarter 2024 and provided a corporate update.

Related news

BLTEBelite Bio2026-05-20 10:00 EST

Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update

BLTEBelite Bio2026-05-13 20:00 EST

Belite Bio to Host Webcast on May 20, 2026, to Discuss First Quarter 2026 Financial Results

ALTAltimmune2026-05-13 11:30 EST

Altimmune Announces First Quarter 2026 Financial Results and Business Update

MISTMilestone Pharmaceuticals Inc.2026-05-13 11:11 EST

Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update

VANIVivani Medical2026-08-13 20:05 EST

Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

ALTAltimmune2026-08-12 11:30 EST

Altimmune Announces Second Quarter 2026 Financial Results and Business Update

MISTMilestone Pharmaceuticals Inc.2026-08-12 11:08 EST

Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update

MLYSMineralys Therapeutics2026-08-11 20:05 EST

Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

SGMTSagimet Biosciences2026-08-11 11:30 EST

Sagimet Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

EMBCEmbecta2026-08-07 10:30 EST

Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results

View all latest news

Synlogic

Synlogic was a synthetic-biology company focused on engineered microbes and metabolic disease before its restructuring and decline. Its platform aimed to use living medicines to address rare disorders.

Recent company news

SYBXSynlogic2026-07-29 11:00 EST

Synlogic and Caldera Therapeutics Announce Merger Agreement and Concurrent Private Placement

SYBXSynlogic2024-11-12 21:35 EST

Synlogic Reports Third Quarter 2024 Financial Results

SYBXSynlogic2024-08-08 11:00 EST

Synlogic Reports Second Quarter 2024 Financial Results

SYBXSynlogic2024-05-14 11:00 EST

Synlogic Reports First Quarter 2024 Financial Results

SYBXSynlogic2024-03-19 11:00 EST

Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results

Stock data

Close
1.07 USD
Market cap
—
Exchange
NASDAQ
Sector
Biopharma
Location
United States